This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klevecz, R. R. Articles by Braly, P. S. Search for Related Content PubMed PubMed Citation Articles by Klevecz, R. R. Articles by Braly, P. S.

Circadian Gating of S Phase in Human Ovarian Cancer¹

Division of Biology, Beckman Research Institute of the City of Hope [R. R. K., R. M. S.], and Department of Gynecologic Oncology, City of Hope National Medical Center [D. B., P. S. B.], Duarte, California 91010

Cell proliferation in 30 patients with ovarian cancer was analyzed using flow cytometry to determine changes in the percentage of cells in S phase. By this measure, proliferation in tumor cells appears to follow a cyclical pattern of peaks and troughs that is out of phase with the circadian rhythm in proliferation of normal tissues. In round-the-clock monitoring of replication stages in tumor cells recovered from i.p. lavage fluid in postsurgery patients, peaks of tumor and nontumor cell DNA synthesis commonly occurred at different times of day. When patients were grouped so that only tumor cell proliferation was being measured, a highly significant 24-h rhythm nearly 12 h out of phase with nontumor cell proliferation was found. This peak in the percentage of S-phase cells occurs most commonly in mid- to late morning and appears to offer an opportunity for timing chemotherapy to coincide with high tumor cell vulnerability and low toxicity to normal tissue.

¹ Supported in part by the Beckman Research Institute Endowment, the Thomas Moses Research Fellowship, and NIH Cancer Center Support Grant CA33572.

Received 3/13/87. Revised 8/10/87. Accepted 9/ 1/87.

This article has been cited by other articles:

				P. A. Wood, J. Du-Quiton, S. You, and W. J.M. Hrushesky Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol. Cancer Ther., August 1, 2006; 5(8): 2023 - 2033. [Abstract] [Full Text] [PDF]

				L. Canaple, T. Kakizawa, and V. Laudet The Days and Nights of Cancer Cells Cancer Res., November 15, 2003; 63(22): 7545 - 7552. [Abstract] [Full Text] [PDF]

				C. G. Lis, J. F. Grutsch, P. Wood, M. You, I. Rich, and W. J M Hrushesky Circadian Timing in Cancer Treatment: The Biological Foundation for an Integrative Approach Integr Cancer Ther, June 1, 2003; 2(2): 105 - 111. [Abstract] [PDF]

				I. EDERY Circadian rhythms in a nutshell Physiol Genomics, August 9, 2000; 3(2): 59 - 74. [Abstract] [Full Text] [PDF]

				L. De Francesco and R. R. Klevecz Replication synchrony-PCR: A sampling-time-independent assay for replication synchrony in human tissues and tumors in situ PNAS, April 15, 1997; 94(8): 4045 - 4049. [Abstract] [Full Text] [PDF]